Cancer drugs now cost more than $100,000 a year for 95% of newly launched therapies, and even with insurance, the out-of-pocket burden can be staggering. Between 2% and 35% of cancer patients end up in medical debt or borrow money to cover treatment. But there are real options for reducing what you pay, and most patients leave money on the table simply because they don’t know where to look. Here’s a practical breakdown of every major path to affording cancer medication.
Start With a Financial Navigator
Before you research individual programs on your own, find out whether your cancer center has a financial navigator or financial counselor on staff. These specialists exist specifically to connect patients with every available source of aid, from grants to insurance optimization to drug discounts. In one NCI-supported study, patients who worked with a financial navigator saved an average of about $2,500 each. At Levine Cancer Institute, a financial navigation team helped patients avoid up to $60 million in costs over two years, including drug cost credits and co-pay assistance.
Most large cancer centers and many community oncology practices employ financial navigators. If yours doesn’t, ask your oncologist’s office for a referral to a social worker who handles insurance and payment issues. This single step often unlocks several of the programs described below, because navigators know which funds are currently open and how to apply quickly.
Manufacturer Patient Assistance Programs
Nearly every company that makes a cancer drug offers a patient assistance program (PAP) that provides the medication free or at a steep discount to qualifying patients. Eligibility is usually based on income, though the thresholds vary widely. Some programs cap eligibility at 200% of the federal poverty level, while others go as high as 750% of the poverty level, which for a single person in 2025 is roughly $112,000 a year. About half of manufacturers don’t publicly disclose their income cutoffs, so it’s worth applying even if you assume you won’t qualify.
To find the right program, search the drug manufacturer’s website for “patient assistance” or call the number on your medication’s packaging. You can also use clearinghouses like NeedyMeds or RxAssist, which aggregate PAPs into searchable databases. Applications typically require proof of income, a prescription, and a doctor’s signature. Approval can take a few days to a few weeks, so apply as early as possible after your treatment plan is set.
Co-pay Assistance Foundations
If you have insurance but your co-pays or coinsurance are unmanageable, nonprofit foundations can cover part or all of those costs. The CancerCare Co-Payment Assistance Foundation (CCAF) is one of the largest, covering co-payments, coinsurance, and deductibles specifically for chemotherapy and targeted treatment medications. Other major sources include the Patient Advocate Foundation’s Co-Pay Relief Program, the HealthWell Foundation, the Leukemia & Lymphoma Society’s co-pay assistance program, and PAN Foundation.
These funds are disease-specific and open and close throughout the year as money comes in and runs out. When a fund for your cancer type is open, apply immediately. Many close within days. Financial navigators often monitor these openings in real time, which is another reason to have one in your corner. One important restriction: these foundations serve insured patients. If you’re uninsured, manufacturer PAPs or hospital charity care are better starting points.
Co-pay Cards From Drug Makers
Many manufacturers also offer co-pay savings cards that reduce what you pay at the pharmacy, sometimes to as little as $0 per fill. These work well if you have private or employer-sponsored insurance. However, if you’re on Medicare, Medicaid, or any other federal health program, you cannot use manufacturer co-pay cards. Federal anti-kickback laws treat these cards as improper financial incentives when a government program is involved. Medicare patients should look to the nonprofit co-pay foundations listed above instead, which operate under specific legal exemptions.
Medicare Part D’s New Spending Cap
If you’re on Medicare, the Inflation Reduction Act introduced a major change. Starting in 2025, total out-of-pocket spending on Part D prescription drugs is capped at $2,000 per year. In 2026, that cap rises slightly to $2,100. Once you hit that threshold, you enter catastrophic coverage and pay nothing more for prescriptions for the rest of the year. Before this cap existed, some Medicare patients faced tens of thousands of dollars in drug costs annually, and half of older adults didn’t fill their cancer prescriptions when out-of-pocket costs exceeded $2,000.
Medicare also allows you to spread that $2,000 across monthly payments rather than paying it all upfront in the first months of treatment when costs are heaviest. Ask your Part D plan about the Medicare Prescription Payment Plan, which breaks your annual costs into predictable monthly installments.
State Pharmaceutical Assistance Programs
More than 30 states run pharmaceutical assistance programs that can supplement Medicare Part D or help uninsured and underinsured residents. Some provide wraparound coverage for costs that Part D doesn’t pay. Examples include Pennsylvania’s PACE and PACENET programs for older adults, New York’s EPIC program, New Jersey’s PAAD, Wisconsin’s SeniorCare, and Massachusetts’ Prescription Advantage. Eligibility rules and covered medications vary by state.
To find your state’s program, search the National Conference of State Legislatures’ directory of State Pharmaceutical Assistance Programs, or call your state’s department of health or aging services. Many patients don’t realize these programs exist, and enrollment is often straightforward.
Hospital Financial Assistance and Charity Care
If you receive treatment at a nonprofit hospital, federal law requires that facility to have a written financial assistance policy. Under Section 501(r) of the tax code, nonprofit hospitals must publicize who qualifies for free or reduced-cost care, limit what they charge uninsured and qualifying patients, and follow specific rules before sending bills to collections. These policies typically cover people with incomes below a certain threshold, often 200% to 400% of the federal poverty level, though each hospital sets its own criteria.
You don’t need to be uninsured to qualify. If your insurance leaves you with large balances for infusions, hospital-administered drugs, or related services, you can apply for financial assistance on those remaining charges. Ask the hospital’s billing department for a financial assistance application before your first bill arrives. Many hospitals will also retroactively apply assistance to bills you’ve already received.
Clinical Trials
Enrolling in a clinical trial can provide access to newer cancer drugs at no cost for the drug itself. Trial sponsors typically cover research costs, which include the study drug, any lab tests done purely for the trial, imaging performed solely for research purposes, and extra doctor visits required by the study protocol. Your insurance is then responsible for routine patient care costs you’d have regardless of the trial, like standard doctor visits, hospital stays, and management of side effects.
Some trials also offer stipends or reimbursement for travel, lodging, meals, and parking. Ask the research team directly whether the study provides financial support or can connect you with organizations that help cover those expenses. You can search for open trials at ClinicalTrials.gov or the National Cancer Institute’s trial search tool, filtering by your cancer type and location.
Appealing an Insurance Denial
If your insurer denies coverage for a prescribed cancer drug, you have the legal right to challenge that decision. The process has two stages. First, you file an internal appeal, asking the insurance company to conduct a full review of its own decision. If the situation is urgent, meaning a delay could seriously harm your health, the insurer must expedite this review. If the internal appeal is denied, you can request an external review, where an independent third party evaluates the case. At that point, the insurance company no longer has the final say.
Your insurer is required to explain why it denied your claim and tell you how to dispute it. Your oncologist’s office can strengthen your appeal by providing a letter of medical necessity explaining why the specific drug is essential for your treatment. Many denials are overturned on appeal, particularly when clinical documentation supports the prescribing decision, so don’t accept a denial as the final answer.
Putting It All Together
The most effective approach combines several of these strategies. A typical patient might use insurance as the primary payer, apply for a co-pay assistance grant to cover the remaining cost share, and have a hospital financial assistance application on file for infusion-related charges. Someone on Medicare might rely on the $2,000 annual cap, spread payments monthly, and layer on a state pharmaceutical assistance program to cover other medications. An uninsured patient might qualify for both a manufacturer’s free drug program and hospital charity care pricing.
The single most important step is asking for help early. Half of patients who face high out-of-pocket costs simply don’t fill their prescriptions, and 30% of commercially insured patients with the highest co-pays stop taking their oral cancer medications. These outcomes are preventable. Contact your cancer center’s financial counselor, apply to every program you might qualify for, and don’t rule yourself out before you’ve submitted an application.